Prevalence and clinical significance of anticardiolipin and anti-β2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma

European Journal of Haematology

Volumn 68, Issue 2, 2002, Pages 84-90

  Genvresse, I ^a   Luftner D ^a   Spath Schwalbe E ^b   Buttgereit, F ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Vivantes Klinikum Spandau   (Germany)

Author keywords

Anti 2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Non Hodgkin's lymphoma; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY;

ADOLESCENT; ADULT; AGED; AGING; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; THROMBOEMBOLISM;

EID: 0036245428     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2002.01526.x     Document Type: Article

References (21)

1. Guidelines on the investigation and management of the antiphospholipid syndrome
2. Association of anti-β2-glycoprotein-I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
3. Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients
4. Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients
5. Multiple autoantibody production in a patient with splenic lymphoma
6. Progressive thrombosis after treatment of diffuse large cell non-Hodgkin's lymphoma and concomitant lupus anticoagulant
7. Anti-phospholipid antibody syndrome associated with peripheral T-cell lymphoma
8. Antiphospholipid antibodies: Prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma
9. Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases
10. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects
11. Prevalence of antibodies to anti-β2-glycoprotein-I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: A single center study and literature review
12. The emerging concept of pathogenic natural autoantibodies
13. Increased natural antibody in sera of patients with malignant non-Hodgkin's lymphomas containing paraproteins
14. Arterial thrombosis associated with anticardiolipin and anti-β2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: A report of two cases
15. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: Correlation with elevated polyclonal IgM and implications for patients with repeated abortion
16. Anticardiolipin antibodies and physical disability in the elderly
17. Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders
18. Clinical trials on antiphospholipid syndrome: What is being done and what is needed?
19. Lupus anticoagulants and thrombosis: Clinical association of different coagulation and immunologic tests
20. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and β2-glycoprotein-I-dependent antiphospholipid antibodies
21. Deep venous thrombosis and pulmonary artery embolism in high-grade non-Hodgkin's lymphoma: Incidence, causes and prognostic relevance